nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—Vismodegib—skin cancer	0.546	1	CrCtD
Sulfasalazine—Sulfapyridine—Vismodegib—skin cancer	0.182	1	CrCrCtD
Sulfasalazine—PTGS2—skin cancer	0.0935	1	CbGaD
Sulfasalazine—ABCG2—Vismodegib—skin cancer	0.0346	0.295	CbGbCtD
Sulfasalazine—ABCG2—Vemurafenib—skin cancer	0.0274	0.233	CbGbCtD
Sulfasalazine—ABCG2—Dactinomycin—skin cancer	0.0182	0.155	CbGbCtD
Sulfasalazine—ABCG2—Fluorouracil—skin cancer	0.0123	0.105	CbGbCtD
Sulfasalazine—ABCC2—Docetaxel—skin cancer	0.0104	0.0884	CbGbCtD
Sulfasalazine—ABCG2—Docetaxel—skin cancer	0.00939	0.08	CbGbCtD
Sulfasalazine—CYP3A5—Docetaxel—skin cancer	0.0052	0.0443	CbGbCtD
Sulfasalazine—SLC7A11—forelimb zeugopod—skin cancer	0.0036	0.0971	CbGeAlD
Sulfasalazine—TBXAS1—leg—skin cancer	0.00248	0.067	CbGeAlD
Sulfasalazine—TBXAS1—forelimb—skin cancer	0.00246	0.0665	CbGeAlD
Sulfasalazine—TBXAS1—hindlimb—skin cancer	0.00222	0.0599	CbGeAlD
Sulfasalazine—TBXAS1—appendage—skin cancer	0.0019	0.0513	CbGeAlD
Sulfasalazine—Vismodegib—SHH—skin cancer	0.00147	0.576	CrCbGaD
Sulfasalazine—PPARG—dermis—skin cancer	0.00142	0.0383	CbGeAlD
Sulfasalazine—PPARG—leg—skin cancer	0.000936	0.0253	CbGeAlD
Sulfasalazine—PPARG—forelimb—skin cancer	0.000929	0.0251	CbGeAlD
Sulfasalazine—PLA2G1B—blood vessel—skin cancer	0.000887	0.024	CbGeAlD
Sulfasalazine—Vismodegib—SMO—skin cancer	0.000845	0.331	CrCbGaD
Sulfasalazine—PPARG—hindlimb—skin cancer	0.000835	0.0226	CbGeAlD
Sulfasalazine—PPARG—appendage—skin cancer	0.000717	0.0194	CbGeAlD
Sulfasalazine—ACAT1—connective tissue—skin cancer	0.000649	0.0175	CbGeAlD
Sulfasalazine—TBXAS1—connective tissue—skin cancer	0.000543	0.0147	CbGeAlD
Sulfasalazine—CHUK—connective tissue—skin cancer	0.000484	0.0131	CbGeAlD
Sulfasalazine—PTGS2—leg—skin cancer	0.000478	0.0129	CbGeAlD
Sulfasalazine—IKBKB—nipple—skin cancer	0.000464	0.0125	CbGeAlD
Sulfasalazine—CHUK—epithelium—skin cancer	0.000459	0.0124	CbGeAlD
Sulfasalazine—ACAT1—female reproductive system—skin cancer	0.000458	0.0124	CbGeAlD
Sulfasalazine—PLA2G1B—connective tissue—skin cancer	0.000455	0.0123	CbGeAlD
Sulfasalazine—CHUK—skin of body—skin cancer	0.000437	0.0118	CbGeAlD
Sulfasalazine—PPARG—endothelium—skin cancer	0.000433	0.0117	CbGeAlD
Sulfasalazine—PLA2G1B—epithelium—skin cancer	0.000432	0.0117	CbGeAlD
Sulfasalazine—PTGS2—hindlimb—skin cancer	0.000427	0.0115	CbGeAlD
Sulfasalazine—PPARG—blood vessel—skin cancer	0.000399	0.0108	CbGeAlD
Sulfasalazine—TBXAS1—lymphoid tissue—skin cancer	0.000397	0.0107	CbGeAlD
Sulfasalazine—ACAT1—head—skin cancer	0.000382	0.0103	CbGeAlD
Sulfasalazine—PTGS2—appendage—skin cancer	0.000366	0.00989	CbGeAlD
Sulfasalazine—CHUK—lymphoid tissue—skin cancer	0.000354	0.00955	CbGeAlD
Sulfasalazine—SLC46A1—lymphoid tissue—skin cancer	0.000354	0.00955	CbGeAlD
Sulfasalazine—CHUK—female reproductive system—skin cancer	0.000341	0.00921	CbGeAlD
Sulfasalazine—IKBKB—connective tissue—skin cancer	0.000329	0.00888	CbGeAlD
Sulfasalazine—PLA2G1B—female reproductive system—skin cancer	0.000321	0.00866	CbGeAlD
Sulfasalazine—TBXAS1—head—skin cancer	0.00032	0.00863	CbGeAlD
Sulfasalazine—PTGS2—skin epidermis—skin cancer	0.000305	0.00823	CbGeAlD
Sulfasalazine—IKBKB—skin of body—skin cancer	0.000297	0.00802	CbGeAlD
Sulfasalazine—PPARG—nipple—skin cancer	0.000288	0.00779	CbGeAlD
Sulfasalazine—PPARG—neck—skin cancer	0.000285	0.00771	CbGeAlD
Sulfasalazine—CHUK—head—skin cancer	0.000285	0.0077	CbGeAlD
Sulfasalazine—SLC46A1—head—skin cancer	0.000285	0.0077	CbGeAlD
Sulfasalazine—SLC7A11—female reproductive system—skin cancer	0.000281	0.00759	CbGeAlD
Sulfasalazine—ALOX5—connective tissue—skin cancer	0.000272	0.00736	CbGeAlD
Sulfasalazine—IKBKB—mammalian vulva—skin cancer	0.000271	0.00731	CbGeAlD
Sulfasalazine—PLA2G1B—head—skin cancer	0.000268	0.00724	CbGeAlD
Sulfasalazine—ACAT1—lymph node—skin cancer	0.000268	0.00723	CbGeAlD
Sulfasalazine—IKBKB—lymphoid tissue—skin cancer	0.00024	0.00649	CbGeAlD
Sulfasalazine—SLC7A11—head—skin cancer	0.000235	0.00634	CbGeAlD
Sulfasalazine—IKBKB—female reproductive system—skin cancer	0.000232	0.00626	CbGeAlD
Sulfasalazine—PTGS1—endothelium—skin cancer	0.000231	0.00625	CbGeAlD
Sulfasalazine—TBXAS1—lymph node—skin cancer	0.000224	0.00605	CbGeAlD
Sulfasalazine—PTGS2—endothelium—skin cancer	0.000221	0.00597	CbGeAlD
Sulfasalazine—PTGS1—blood vessel—skin cancer	0.000213	0.00576	CbGeAlD
Sulfasalazine—PPARG—connective tissue—skin cancer	0.000205	0.00553	CbGeAlD
Sulfasalazine—PTGS2—blood vessel—skin cancer	0.000204	0.00551	CbGeAlD
Sulfasalazine—SLC46A1—lymph node—skin cancer	0.0002	0.00539	CbGeAlD
Sulfasalazine—CHUK—lymph node—skin cancer	0.0002	0.00539	CbGeAlD
Sulfasalazine—ALOX5—lymphoid tissue—skin cancer	0.000199	0.00538	CbGeAlD
Sulfasalazine—PPARG—epithelium—skin cancer	0.000194	0.00525	CbGeAlD
Sulfasalazine—IKBKB—head—skin cancer	0.000194	0.00523	CbGeAlD
Sulfasalazine—ALOX5—female reproductive system—skin cancer	0.000192	0.00519	CbGeAlD
Sulfasalazine—PPARG—skin of body—skin cancer	0.000185	0.00499	CbGeAlD
Sulfasalazine—PPARG—mammalian vulva—skin cancer	0.000168	0.00455	CbGeAlD
Sulfasalazine—SLCO1B1—female reproductive system—skin cancer	0.000167	0.00452	CbGeAlD
Sulfasalazine—ALOX5—head—skin cancer	0.000161	0.00434	CbGeAlD
Sulfasalazine—PTGS1—nipple—skin cancer	0.000154	0.00416	CbGeAlD
Sulfasalazine—PPARG—lymphoid tissue—skin cancer	0.00015	0.00404	CbGeAlD
Sulfasalazine—PPARG—female reproductive system—skin cancer	0.000144	0.0039	CbGeAlD
Sulfasalazine—IKBKB—lymph node—skin cancer	0.000136	0.00366	CbGeAlD
Sulfasalazine—Balsalazide—PTGS2—skin cancer	0.000129	0.0507	CrCbGaD
Sulfasalazine—ABCC2—female reproductive system—skin cancer	0.000127	0.00342	CbGeAlD
Sulfasalazine—PPARG—head—skin cancer	0.000121	0.00326	CbGeAlD
Sulfasalazine—ALOX5—lymph node—skin cancer	0.000112	0.00304	CbGeAlD
Sulfasalazine—Olsalazine—PTGS2—skin cancer	0.00011	0.0431	CrCbGaD
Sulfasalazine—PTGS1—connective tissue—skin cancer	0.000109	0.00295	CbGeAlD
Sulfasalazine—ABCG2—mammalian vulva—skin cancer	0.000108	0.00292	CbGeAlD
Sulfasalazine—PTGS2—connective tissue—skin cancer	0.000105	0.00282	CbGeAlD
Sulfasalazine—PTGS1—epithelium—skin cancer	0.000104	0.0028	CbGeAlD
Sulfasalazine—PTGS2—epithelium—skin cancer	9.92e-05	0.00268	CbGeAlD
Sulfasalazine—PTGS1—skin of body—skin cancer	9.87e-05	0.00267	CbGeAlD
Sulfasalazine—PTGS2—skin of body—skin cancer	9.44e-05	0.00255	CbGeAlD
Sulfasalazine—PTGS1—mammalian vulva—skin cancer	9.01e-05	0.00243	CbGeAlD
Sulfasalazine—PPARG—lymph node—skin cancer	8.44e-05	0.00228	CbGeAlD
Sulfasalazine—PTGS1—female reproductive system—skin cancer	7.71e-05	0.00208	CbGeAlD
Sulfasalazine—PTGS2—lymphoid tissue—skin cancer	7.64e-05	0.00206	CbGeAlD
Sulfasalazine—ABCC2—lymph node—skin cancer	7.42e-05	0.002	CbGeAlD
Sulfasalazine—PTGS2—female reproductive system—skin cancer	7.37e-05	0.00199	CbGeAlD
Sulfasalazine—PTGS1—head—skin cancer	6.44e-05	0.00174	CbGeAlD
Sulfasalazine—PTGS2—head—skin cancer	6.16e-05	0.00166	CbGeAlD
Sulfasalazine—ABCG2—lymph node—skin cancer	5.41e-05	0.00146	CbGeAlD
Sulfasalazine—PTGS1—lymph node—skin cancer	4.51e-05	0.00122	CbGeAlD
Sulfasalazine—PTGS2—lymph node—skin cancer	4.31e-05	0.00116	CbGeAlD
Sulfasalazine—PPARG—Metabolism—CSPG4—skin cancer	1.61e-05	0.000722	CbGpPWpGaD
Sulfasalazine—IKBKB—MyD88-independent cascade—IL6—skin cancer	1.6e-05	0.000721	CbGpPWpGaD
Sulfasalazine—CHUK—Activated TLR4 signalling—IL6—skin cancer	1.59e-05	0.000716	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.59e-05	0.000715	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—NRAS—skin cancer	1.59e-05	0.000714	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—NRAS—skin cancer	1.59e-05	0.000714	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—NRAS—skin cancer	1.59e-05	0.000714	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—NRAS—skin cancer	1.57e-05	0.000707	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PLIN2—skin cancer	1.57e-05	0.000706	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—KRAS—skin cancer	1.57e-05	0.000705	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—PTGS2—skin cancer	1.57e-05	0.000705	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-like Receptor Signaling Pathway—IL6—skin cancer	1.57e-05	0.000704	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by Interleukins—HRAS—skin cancer	1.56e-05	0.000703	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—BRAF—skin cancer	1.56e-05	0.000702	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—NRAS—skin cancer	1.56e-05	0.000701	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—NRAS—skin cancer	1.55e-05	0.000698	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—KRAS—skin cancer	1.55e-05	0.000698	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—KRAS—skin cancer	1.54e-05	0.000694	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—BRAF—skin cancer	1.53e-05	0.00069	CbGpPWpGaD
Sulfasalazine—PPARG—Adipogenesis—IL6—skin cancer	1.52e-05	0.000682	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTCH2—skin cancer	1.51e-05	0.000678	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NRAS—skin cancer	1.51e-05	0.000678	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—NRAS—skin cancer	1.5e-05	0.000675	CbGpPWpGaD
Sulfasalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—skin cancer	1.5e-05	0.000673	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by Interleukins—IL6—skin cancer	1.5e-05	0.000673	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—KRAS—skin cancer	1.47e-05	0.000663	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—KRAS—skin cancer	1.47e-05	0.000661	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—NRAS—skin cancer	1.47e-05	0.000661	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—NRAS—skin cancer	1.47e-05	0.000661	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—KRAS—skin cancer	1.47e-05	0.000659	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—KRAS—skin cancer	1.46e-05	0.000656	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PLIN2—skin cancer	1.45e-05	0.000653	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—KRAS—skin cancer	1.45e-05	0.000653	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—IL6—skin cancer	1.45e-05	0.000652	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—ERCC2—skin cancer	1.45e-05	0.00065	CbGpPWpGaD
Sulfasalazine—IKBKB—Activated TLR4 signalling—IL6—skin cancer	1.44e-05	0.000649	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—NRAS—skin cancer	1.44e-05	0.000647	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KRAS—skin cancer	1.43e-05	0.000644	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—NRAS—skin cancer	1.41e-05	0.000632	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PLIN2—skin cancer	1.4e-05	0.000628	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—HRAS—skin cancer	1.39e-05	0.000626	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.38e-05	0.00062	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—TP53—skin cancer	1.38e-05	0.00062	CbGpPWpGaD
Sulfasalazine—CHUK—BDNF signaling pathway—HRAS—skin cancer	1.37e-05	0.000616	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—KRAS—skin cancer	1.37e-05	0.000614	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—KRAS—skin cancer	1.37e-05	0.000614	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—KRAS—skin cancer	1.37e-05	0.000614	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—skin cancer	1.36e-05	0.00061	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—KRAS—skin cancer	1.35e-05	0.000609	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	1.35e-05	0.000606	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—KRAS—skin cancer	1.34e-05	0.000603	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—CDK4—skin cancer	1.34e-05	0.000602	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—KRAS—skin cancer	1.34e-05	0.000601	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—IL6—skin cancer	1.33e-05	0.0006	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-Like Receptors Cascades—IL6—skin cancer	1.33e-05	0.0006	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—HRAS—skin cancer	1.33e-05	0.000599	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—NRAS—skin cancer	1.33e-05	0.000599	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—HRAS—skin cancer	1.31e-05	0.00059	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—skin cancer	1.3e-05	0.000584	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—KRAS—skin cancer	1.29e-05	0.000581	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.29e-05	0.000578	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—IL6—skin cancer	1.28e-05	0.000574	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CSPG4—skin cancer	1.26e-05	0.000569	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—KRAS—skin cancer	1.26e-05	0.000569	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—KRAS—skin cancer	1.26e-05	0.000569	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—GLI2—skin cancer	1.26e-05	0.000567	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—IL6—skin cancer	1.26e-05	0.000565	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—HRAS—skin cancer	1.25e-05	0.000563	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—HRAS—skin cancer	1.25e-05	0.000562	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—HRAS—skin cancer	1.25e-05	0.000561	CbGpPWpGaD
Sulfasalazine—IKBKB—BDNF signaling pathway—HRAS—skin cancer	1.24e-05	0.000559	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—HRAS—skin cancer	1.24e-05	0.000558	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—PTGS2—skin cancer	1.24e-05	0.000558	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—skin cancer	1.24e-05	0.000557	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—HRAS—skin cancer	1.23e-05	0.000555	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—ENO2—skin cancer	1.22e-05	0.00055	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—SHH—skin cancer	1.22e-05	0.00055	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	1.22e-05	0.00055	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—skin cancer	1.22e-05	0.000547	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	1.21e-05	0.000544	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-Like Receptors Cascades—IL6—skin cancer	1.21e-05	0.000544	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MC1R—skin cancer	1.2e-05	0.000541	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—IL6—skin cancer	1.2e-05	0.000539	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—IL6—skin cancer	1.19e-05	0.000537	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—PTGS2—skin cancer	1.19e-05	0.000534	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—IL6—skin cancer	1.19e-05	0.000534	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—GLI1—skin cancer	1.19e-05	0.000533	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—IL6—skin cancer	1.18e-05	0.000531	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CSPG4—skin cancer	1.17e-05	0.000527	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—TP53—skin cancer	1.17e-05	0.000525	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	1.16e-05	0.000522	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—HRAS—skin cancer	1.16e-05	0.000522	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—HRAS—skin cancer	1.16e-05	0.000522	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—IL6—skin cancer	1.15e-05	0.000518	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—HRAS—skin cancer	1.15e-05	0.000518	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TP53—skin cancer	1.15e-05	0.000516	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—KRAS—skin cancer	1.15e-05	0.000516	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GLI2—skin cancer	1.14e-05	0.000514	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.14e-05	0.000514	CbGpPWpGaD
Sulfasalazine—IKBKB—Insulin Signaling—HRAS—skin cancer	1.14e-05	0.000513	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—HRAS—skin cancer	1.14e-05	0.000513	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—HRAS—skin cancer	1.14e-05	0.000511	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CSPG4—skin cancer	1.12e-05	0.000506	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SUFU—skin cancer	1.12e-05	0.000505	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—TP53—skin cancer	1.12e-05	0.000505	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	1.11e-05	0.0005	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—IL6—skin cancer	1.11e-05	0.0005	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—IL6—skin cancer	1.11e-05	0.0005	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PLIN2—skin cancer	1.11e-05	0.000498	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—skin cancer	1.1e-05	0.000496	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—IL6—skin cancer	1.1e-05	0.000495	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—NRAS—skin cancer	1.1e-05	0.000495	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ENO2—skin cancer	1.09e-05	0.000491	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—IL6—skin cancer	1.09e-05	0.000491	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MC1R—skin cancer	1.09e-05	0.00049	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—IL6—skin cancer	1.09e-05	0.000489	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—NRAS—skin cancer	1.08e-05	0.000486	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—FOXO4—skin cancer	1.08e-05	0.000486	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GLI1—skin cancer	1.07e-05	0.000483	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—HRAS—skin cancer	1.07e-05	0.000483	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—HRAS—skin cancer	1.07e-05	0.000483	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—IL6—skin cancer	1.07e-05	0.000481	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CSPG4—skin cancer	1.07e-05	0.00048	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	1.05e-05	0.000474	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PLIN2—skin cancer	1.04e-05	0.000468	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—PTGS2—skin cancer	1.04e-05	0.000467	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	1.03e-05	0.000463	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—ERCC2—skin cancer	1.02e-05	0.000461	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SUFU—skin cancer	1.02e-05	0.000458	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	1.01e-05	0.000453	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—FOXO4—skin cancer	9.98e-06	0.000449	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—NRAS—skin cancer	9.97e-06	0.000448	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TP53—skin cancer	9.95e-06	0.000447	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	9.84e-06	0.000443	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—NRAS—skin cancer	9.8e-06	0.000441	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—FOXO4—skin cancer	9.8e-06	0.000441	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—HRAS—skin cancer	9.74e-06	0.000438	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—NRAS—skin cancer	9.65e-06	0.000434	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—KRAS—skin cancer	9.46e-06	0.000426	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—KRAS—skin cancer	9.31e-06	0.000419	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—IL6—skin cancer	9.11e-06	0.00041	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CSPG4—skin cancer	8.93e-06	0.000402	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—PTGS2—skin cancer	8.66e-06	0.00039	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ENO2—skin cancer	8.6e-06	0.000387	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—KRAS—skin cancer	8.58e-06	0.000386	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SHH—skin cancer	8.57e-06	0.000385	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	8.54e-06	0.000384	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—RASA1—skin cancer	8.52e-06	0.000383	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—KRAS—skin cancer	8.44e-06	0.00038	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CSPG4—skin cancer	8.39e-06	0.000377	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—KRAS—skin cancer	8.3e-06	0.000373	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—ERCC2—skin cancer	8.15e-06	0.000367	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SMO—skin cancer	8.12e-06	0.000365	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PTCH1—skin cancer	8.12e-06	0.000365	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HRAS—skin cancer	8.04e-06	0.000362	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ENO2—skin cancer	7.96e-06	0.000358	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—HRAS—skin cancer	7.91e-06	0.000356	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PTGER4—skin cancer	7.91e-06	0.000356	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SHH—skin cancer	7.77e-06	0.000349	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—RASA1—skin cancer	7.72e-06	0.000347	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IL6—skin cancer	7.7e-06	0.000346	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ENO2—skin cancer	7.65e-06	0.000344	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	7.61e-06	0.000342	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—IL6—skin cancer	7.57e-06	0.00034	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—NRAS—skin cancer	7.44e-06	0.000335	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SMO—skin cancer	7.37e-06	0.000331	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTCH1—skin cancer	7.37e-06	0.000331	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HRAS—skin cancer	7.29e-06	0.000328	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SHH—skin cancer	7.25e-06	0.000326	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ENO2—skin cancer	7.25e-06	0.000326	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—HRAS—skin cancer	7.17e-06	0.000323	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTGER4—skin cancer	7.17e-06	0.000323	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—ERCC2—skin cancer	7.11e-06	0.00032	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—HRAS—skin cancer	7.06e-06	0.000317	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FOXO4—skin cancer	6.99e-06	0.000314	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL6—skin cancer	6.98e-06	0.000314	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—IL6—skin cancer	6.86e-06	0.000309	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	6.77e-06	0.000304	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—IL6—skin cancer	6.75e-06	0.000304	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.72e-06	0.000302	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TERT—skin cancer	6.66e-06	0.0003	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—KRAS—skin cancer	6.4e-06	0.000288	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ERCC2—skin cancer	6.34e-06	0.000285	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FOXO4—skin cancer	6.33e-06	0.000285	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—NRAS—skin cancer	6.17e-06	0.000277	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PTGS2—skin cancer	6.14e-06	0.000276	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ENO2—skin cancer	6.07e-06	0.000273	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.98e-06	0.000269	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—NRAS—skin cancer	5.92e-06	0.000266	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FOXO4—skin cancer	5.91e-06	0.000266	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ENO2—skin cancer	5.7e-06	0.000256	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—NRAS—skin cancer	5.59e-06	0.000251	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—HRAS—skin cancer	5.44e-06	0.000245	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—NRAS—skin cancer	5.37e-06	0.000242	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—KRAS—skin cancer	5.31e-06	0.000239	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—BRAF—skin cancer	5.28e-06	0.000237	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—IL6—skin cancer	5.21e-06	0.000234	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—KRAS—skin cancer	5.1e-06	0.000229	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ERCC2—skin cancer	4.99e-06	0.000225	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—KRAS—skin cancer	4.81e-06	0.000216	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TERT—skin cancer	4.67e-06	0.00021	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ERCC2—skin cancer	4.62e-06	0.000208	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—KRAS—skin cancer	4.62e-06	0.000208	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—HRAS—skin cancer	4.51e-06	0.000203	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ERCC2—skin cancer	4.44e-06	0.0002	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HRAS—skin cancer	4.33e-06	0.000195	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—IL6—skin cancer	4.32e-06	0.000194	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTGS2—skin cancer	4.26e-06	0.000192	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TERT—skin cancer	4.23e-06	0.00019	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ERCC2—skin cancer	4.21e-06	0.000189	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—HRAS—skin cancer	4.09e-06	0.000184	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TERT—skin cancer	3.95e-06	0.000178	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HRAS—skin cancer	3.93e-06	0.000177	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—IL6—skin cancer	3.92e-06	0.000176	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTGS2—skin cancer	3.8e-06	0.000171	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—BRAF—skin cancer	3.69e-06	0.000166	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—NRAS—skin cancer	3.59e-06	0.000162	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ERCC2—skin cancer	3.53e-06	0.000159	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—BRAF—skin cancer	3.35e-06	0.000151	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NRAS—skin cancer	3.32e-06	0.000149	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ERCC2—skin cancer	3.31e-06	0.000149	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—NRAS—skin cancer	3.26e-06	0.000146	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—BRAF—skin cancer	3.13e-06	0.000141	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—KRAS—skin cancer	3.09e-06	0.000139	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTGS2—skin cancer	2.99e-06	0.000135	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—KRAS—skin cancer	2.85e-06	0.000128	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—KRAS—skin cancer	2.8e-06	0.000126	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTGS2—skin cancer	2.77e-06	0.000125	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTGS2—skin cancer	2.66e-06	0.00012	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HRAS—skin cancer	2.63e-06	0.000118	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL6—skin cancer	2.51e-06	0.000113	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HRAS—skin cancer	2.43e-06	0.000109	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HRAS—skin cancer	2.38e-06	0.000107	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NRAS—skin cancer	2.32e-06	0.000104	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—IL6—skin cancer	2.32e-06	0.000104	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL6—skin cancer	2.28e-06	0.000103	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NRAS—skin cancer	2.11e-06	9.47e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KRAS—skin cancer	2e-06	8.99e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTGS2—skin cancer	1.99e-06	8.93e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NRAS—skin cancer	1.96e-06	8.83e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KRAS—skin cancer	1.81e-06	8.15e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—skin cancer	1.78e-06	7.99e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HRAS—skin cancer	1.7e-06	7.64e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KRAS—skin cancer	1.69e-06	7.6e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6—skin cancer	1.63e-06	7.31e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—skin cancer	1.61e-06	7.24e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HRAS—skin cancer	1.54e-06	6.93e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6—skin cancer	1.47e-06	6.63e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HRAS—skin cancer	1.44e-06	6.46e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6—skin cancer	1.38e-06	6.19e-05	CbGpPWpGaD
